Gem Aromatics Ltd
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India.[1]
- Market Cap ₹ 767 Cr.
- Current Price ₹ 147
- High / Low ₹ 350 / 133
- Stock P/E 28.7
- Book Value ₹ 91.1
- Dividend Yield 0.00 %
- ROCE 9.11 %
- ROE 7.03 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Promoter holding has increased by 1.95% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 3.01% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE IPO BSE Commodities Nifty IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 320 | 302 | 413 | 447 | 497 | 371 | |
| 289 | 254 | 354 | 372 | 411 | 332 | |
| Operating Profit | 31 | 48 | 59 | 76 | 86 | 39 |
| OPM % | 10% | 16% | 14% | 17% | 17% | 11% |
| 4 | 3 | 1 | 3 | 5 | 12 | |
| Interest | 2 | 3 | 6 | 6 | 7 | 9 |
| Depreciation | 3 | 4 | 5 | 6 | 7 | 6 |
| Profit before tax | 30 | 44 | 50 | 67 | 77 | 36 |
| Tax % | 22% | 30% | 21% | 26% | 26% | 26% |
| 23 | 31 | 40 | 49 | 57 | 27 | |
| EPS in Rs | 131.60 | 173.79 | 222.48 | 10.56 | 12.13 | 5.11 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | -4% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | -12% |
| TTM: | -53% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 9 | 9 | 10 |
| Reserves | 109 | 139 | 176 | 218 | 275 | 465 |
| 55 | 77 | 89 | 85 | 145 | 90 | |
| 20 | 21 | 25 | 19 | 18 | 22 | |
| Total Liabilities | 187 | 239 | 292 | 331 | 447 | 588 |
| 24 | 27 | 27 | 37 | 37 | 41 | |
| CWIP | 2 | 1 | 11 | 2 | 6 | 0 |
| Investments | 0 | 0 | 0 | 1 | 1 | 101 |
| 160 | 210 | 254 | 292 | 403 | 446 | |
| Total Assets | 187 | 239 | 292 | 331 | 447 | 588 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| -3 | -16 | 12 | 42 | -12 | 95 | |
| -5 | -4 | -13 | -25 | -54 | -190 | |
| 8 | 19 | 7 | -12 | 50 | 99 | |
| Net Cash Flow | -0 | -1 | 6 | 6 | -16 | 5 |
| Free Cash Flow | -9 | -21 | -2 | 36 | -20 | 90 |
| CFO/OP | 12% | -10% | 49% | 76% | 14% | 265% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 80 | 54 | 70 | 35 | 101 | 55 |
| Inventory Days | 94 | 207 | 159 | 180 | 151 | 232 |
| Days Payable | 21 | 27 | 23 | 16 | 15 | 18 |
| Cash Conversion Cycle | 152 | 234 | 205 | 199 | 236 | 269 |
| Working Capital Days | 90 | 119 | 101 | 124 | 114 | 142 |
| ROCE % | 25% | 23% | 25% | 23% | 9% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Actual Production Volume MT |
|
||||
| Installed Production Capacity MTPA |
|||||
| Repeat Customers Revenue Contribution % |
|||||
| Total Number of Customers Number |
|||||
| Market Share - Clove Oil (India) % |
|||||
| Market Share - Eucalyptus Oil (India) % |
|||||
| Market Share - Eugenol (India) % |
|||||
| Number of Products in Portfolio Number |
|||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
26 May - Q4/FY26 investor call transcript filed; Dahej commercial production began, ₹270 crore capex and FY28 guidance discussed.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
22 May - Audio recording of Q4 and FY26 investor conference call held on 22 May 2026 uploaded online.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 22 May
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 May - Gem Aromatics reported Q4FY26 and FY26 results; Dahej capex ~Rs260 Cr, EcoVadis Platinum, new production began 26 Feb 2026.
- Announcement under Regulation 30 (LODR)-Investor Presentation 21 May
Concalls
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
Business Profile[1][2]
The company specializes in producing high-quality essential oils, aroma chemicals, and value-added derivatives. It has a strong foundation in mint- and clove-based products and growing capabilities in eucalyptus and phenol derivatives, it offers a portfolio of around 70 products across four categories. These ingredients find wide applications in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management, as well as personal care segments.